These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 719603)

  • 1. An evaluation of protracted low dose rate irradiation from an acute dose survival curve.
    Konishi K; Horiuchi J
    Cancer; 1978 Nov; 42(5):2211-5. PubMed ID: 719603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isotope selection for permanent prostate implants? An evaluation of 103Pd versus 125I based on radiobiological effectiveness and dosimetry.
    Dicker AP; Lin CC; Leeper DB; Waterman FM
    Semin Urol Oncol; 2000 May; 18(2):152-9. PubMed ID: 10875458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The tritium RBE at low-level exposure--variation with dose, dose rate, and exposure duration.
    Dobson RL; Kwan TC
    Curr Top Radiat Res Q; 1978 Jan; 12(1-4):44-62. PubMed ID: 639559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose rate dependence of the relative biological effectiveness of 103Pd for continuous low dose rate irradiation of BA1112 rhabdomyosarcoma cells in vitro relative to acute exposures.
    Nath R; Bongiorni P; Chen Z; Gragnano J; Rockwell S
    Int J Radiat Biol; 2005 Sep; 81(9):689-99. PubMed ID: 16368647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radiobiological analysis of the use of low-intensity irradiation doses in radiation therapy].
    Kurpeshev OK
    Med Radiol (Mosk); 1980 Aug; 25(8):68-74. PubMed ID: 6995780
    [No Abstract]   [Full Text] [Related]  

  • 6. Influence of different dose rates on cell recovery and RBE at different spatial positions during protracted conformal radiotherapy.
    Herskind C; Schalla S; Hahn EW; Höver KH; Wenz F
    Radiat Prot Dosimetry; 2006; 122(1-4):498-505. PubMed ID: 17223644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Quantitative evaluation of tumor radiation reactions by their radiobiological parameters].
    Lisin VA; Musabaeva LI
    Med Radiol (Mosk); 1983 Dec; 28(12):30-4. PubMed ID: 6645839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Radiobiological investigation of dose-rate effects in intensity-modulated radiation therapy.
    Sterzing F; Münter MW; Schäfer M; Haering P; Rhein B; Thilmann C; Debus J
    Strahlenther Onkol; 2005 Jan; 181(1):42-8. PubMed ID: 15660192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationship between the generalized equivalent uniform dose formulation and the Poisson statistics-based tumor control probability model.
    Zhou SM; Das S; Wang Z; Marks LB
    Med Phys; 2004 Sep; 31(9):2606-9. PubMed ID: 15487743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypothesis. Elkind recovery and "sub-lethal damage": a misleading association?
    Alper T
    Br J Radiol; 1977 Jul; 50(595):459-67. PubMed ID: 326328
    [No Abstract]   [Full Text] [Related]  

  • 11. Dose-rate effects in normal and malignant cells of human origin.
    Marchese MJ; Zaider M; Hall EJ
    Br J Radiol; 1987 Jun; 60(714):573-6. PubMed ID: 3620815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A parametric method for estimation of dose-modifying factors: low-dose extrapolation limit.
    McLarty JW; Thames HD
    Radiat Res; 1977 Jan; 69(1):1-15. PubMed ID: 402014
    [No Abstract]   [Full Text] [Related]  

  • 13. The initial part of the survival curve: does it predict the outcome of fractionated radiotherapy?
    Elkind MM
    Radiat Res; 1988 Jun; 114(3):425-36. PubMed ID: 3287428
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Extra lethal damage due to residual incompletely repaired sublethal damage in hyperfractionated and continuous radiation treatment.
    Chen J; van de Geijn J; Goffman T
    Med Phys; 1991; 18(3):488-96. PubMed ID: 1870493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Radiobiological considerations for pions in radiotherapy.
    Feola J; Maruyama Y
    Oncology; 1971; 25(6):536-57. PubMed ID: 5005971
    [No Abstract]   [Full Text] [Related]  

  • 16. Survival and oncogenic transformation of C3H/10T1/2 cells after extended X irradiation.
    Balcer-Kubiczek EK; Harrison GH
    Radiat Res; 1985 Nov; 104(2 Pt 1):214-23. PubMed ID: 4080975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NSD and cell survival.
    Lokajícek M; Kozubek S; Prokes K
    Br J Radiol; 1979 Jul; 52(619):571-2. PubMed ID: 465942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The statistics of dose/cure relationships for irradiated tumours. Part II.
    Porter EH
    Br J Radiol; 1980 Apr; 53(628):336-45. PubMed ID: 7378702
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiotargeting agents for cancer therapy.
    Kassis AI
    Expert Opin Drug Deliv; 2005 Nov; 2(6):981-91. PubMed ID: 16296803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative analysis of radiobiological models for cell surviving fractions at high doses.
    Andisheh B; Edgren M; Belkić D; Mavroidis P; Brahme A; Lind BK
    Technol Cancer Res Treat; 2013 Apr; 12(2):183-92. PubMed ID: 23098282
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.